Literature DB >> 18311553

[Sclerotherapy for cystic lesions of the head and neck region].

S Knipping1, G Goetze.   

Abstract

Cystic lesions are frequently occurring diseases of the head and neck region. Complete surgical resection near to neurovascular structures can be accompanied by various complications. In selected cases intralesional injection of OK-432 could constitute an alternative. The average success rate of sclerotherapy of lymphatic malformations is 60%. Side effects are rare. Sclerotherapy is a minimally invasive, simple and cost-effective procedure performed without general anaesthesia at the outpatient clinic. Nerve lesions or troublesome scarring do not occur. In residual cases surgical excision is realisable without any difficulty. Repeated injections of sclerotherapy agents represent a disadvantage. Abscess formation has been observed as a rare complication. A malignant disease has to be excluded by cytological examination before commencing sclerotherapy. The intracystic injection of OK-432 is an effective treatment modality for cystic cervical lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18311553     DOI: 10.1007/s00106-008-1669-2

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  37 in total

1.  TREATMENT OF CYSTIC HYGROMA OF THE NECK BY SODIUM MORRHUATE.

Authors:  G Harrower
Journal:  Br Med J       Date:  1933-07-22

2.  OK-432 therapy for a cervical thoracic duct cyst.

Authors:  Takaki Miwa; Shinji Tatsutomi; Toshiaki Tsukatani; Makoto Ito; Mitsuru Furukawa
Journal:  Otolaryngol Head Neck Surg       Date:  2007-05       Impact factor: 3.497

3.  Treatment of ranula in pediatric patients with intralesional injection of OK-432.

Authors:  Heung-Man Lee; Hyun-Woo Lim; Hee Joon Kang; Sung-Won Chae; Soon-Jae Hwang; Kwang-Yoon Jung; Jeong-Soo Woo
Journal:  Laryngoscope       Date:  2006-06       Impact factor: 3.325

4.  25 years' experience with lymphangiomas in children.

Authors:  A Alqahtani; L T Nguyen; H Flageole; K Shaw; J M Laberge
Journal:  J Pediatr Surg       Date:  1999-07       Impact factor: 2.545

5.  [Treatment of lymphangiomas arising around cervico-facial region: surgery, bleomycin therapy and OK-432 therapy].

Authors:  S Ogita; T Tsuto; E Deguchi; K Tokiwa; J Yanagihara; N Iwai
Journal:  Nihon Geka Gakkai Zasshi       Date:  1989-09

6.  Treatment of branchial cleft cyst with intracystic injection of OK-432.

Authors:  Jong-Lyel Roh; Myung-Whun Sung; Kwang Hyun Kim; Chan Il Park
Journal:  Acta Otolaryngol       Date:  2006-05       Impact factor: 1.494

Review 7.  OK-432 (Picibanil) therapy for lymphangiomas in children.

Authors:  J Laranne; L Keski-Nisula; Riitta Rautio; Markus Rautiainen; Mari Airaksinen
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-05       Impact factor: 2.503

8.  Cystic hygroma of the head and neck. A review of 37 cases.

Authors:  P J Emery; C M Bailey; J N Evans
Journal:  J Laryngol Otol       Date:  1984-06       Impact factor: 1.469

9.  [Sclerotherapy with OK-432 for cystic tumors in the neck region].

Authors:  M Bloching; G Götze; M Passmann; K Neumann
Journal:  HNO       Date:  2005-03       Impact factor: 1.284

10.  Treatment of ranula wth intracystic injection of the streptococcal preparation OK-432.

Authors:  Shigeru Fukase; Nobuo Ohta; Kazutoshi Inamura; Masaru Aoyagi
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-03       Impact factor: 1.547

View more
  1 in total

1.  [Lymphatic malformations in the head and neck: experiences with sclerotherapy].

Authors:  S Knipping; V Bau
Journal:  HNO       Date:  2011-07       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.